Literature DB >> 19094837

Acute demyelinating disorders of the central nervous system.

Meghan K Harris, Amir Hadi Maghzi, Masoud Etemadifar, Roger E Kelley, Eduardo Gonzalez-Toledo, Alireza Minagar.   

Abstract

Acute demyelinating disorders of the central nervous system represent some of the most formidable management and therapeutic challenges to clinicians. These disorders include acute relapses of multiple sclerosis, neuromyelitis optica, acute disseminated encephalomyelitis, optic neuritis, and transverse myelitis. This paper summarizes clinical manifestations of these disorders, as well as treatment strategies. Currently, immunosuppression with corticosteroids for the acute events is the mainstay of treatment. Other experimental therapies, which may be effective in certain patients, are discussed.

Entities:  

Year:  2009        PMID: 19094837     DOI: 10.1007/s11940-009-0008-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  29 in total

Review 1.  Plasmapheresis in acute disseminated encephalomyelitis.

Authors:  Chin-Hsien Lin; Jiann-Shing Jeng; Ping-Keung Yip
Journal:  J Clin Apher       Date:  2004       Impact factor: 2.821

Review 2.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

Review 3.  Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.

Authors:  A A Argyriou; N Makris
Journal:  Acta Neurol Scand       Date:  2008-03-11       Impact factor: 3.209

4.  Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin.

Authors:  D J Sahlas; S P Miller; M Guerin; M Veilleux; G Francis
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

5.  A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis.

Authors:  J H Noseworthy; P C O'Brien; T M Petterson; J Weis; L Stevens; W K Peterson; D Sneve; S A Cross; J A Leavitt; R G Auger; B G Weinshenker; D W Dodick; D M Wingerchuk; M Rodriguez
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

6.  Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins.

Authors:  Eli Shahar; Jameel Andraus; David Savitzki; Giora Pilar; Nathaniel Zelnik
Journal:  J Child Neurol       Date:  2002-11       Impact factor: 1.987

7.  Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis.

Authors:  M Nishikawa; T Ichiyama; T Hayashi; K Ouchi; S Furukawa
Journal:  Pediatr Neurol       Date:  1999-08       Impact factor: 3.372

8.  Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

Authors:  S Watanabe; I Nakashima; T Misu; I Miyazawa; Y Shiga; K Fujihara; Y Itoyama
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

9.  Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis.

Authors:  Rommel P Lu; Gary Keilson
Journal:  J Clin Apher       Date:  2006-12       Impact factor: 2.821

10.  Rapid recovery from transverse myelopathy in children treated with methylprednisolone.

Authors:  E Lahat; G Pillar; S Ravid; A Barzilai; A Etzioni; E Shahar
Journal:  Pediatr Neurol       Date:  1998-10       Impact factor: 3.372

View more
  4 in total

Review 1.  Neuroprotection in multiple sclerosis: a therapeutic approach.

Authors:  Amir-Hadi Maghzi; Alireza Minagar; Emmanuelle Waubant
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

2.  Seizure characteristics in multiple sclerosis patients.

Authors:  Vahid Shaygannejad; Fereshteh Ashtari; Mohammad Zare; Majid Ghasemi; Rasul Norouzi; Helia Maghzi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

3.  Co-occurrence of multiple sclerosis and Parkinson disease.

Authors:  Vahid Shaygannejad; Maryam Shirmardi; Leila Dehghani; Helia Maghzi
Journal:  Adv Biomed Res       Date:  2016-04-21

4.  The environmental risk factors in multiple sclerosis susceptibility: A case-control study.

Authors:  Vahid Shaygannejad; Nooshin Rezaie; Zamzam Paknahad; Freshteh Ashtari; Helia Maghzi
Journal:  Adv Biomed Res       Date:  2016-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.